Zhuhai Biotechnology

Nanjing Zhuhai Biotechnology Co., Ltd. is a high-tech enterprise recognized for integrating the production and sales of medical devices, medical consumables, and pharmaceuticals. Established in 2017, the factory was built in 2018 and passed national inspection in 2019. Trial production commenced in 2020, followed by operational launch. Zhuhai Biotechnology Group drives its development through product innovation, positioning itself as a "high-tech medical device and biopharmaceutical industry innovation platform factory." It adopts a marketing service philosophy that integrates "innovation, industrialization, specialization, and academic focus" and constructs its medical ecosystem through a three-in-one innovative model of "government support, capital involvement, and corporate operation."